SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-030109
Filing Date
2022-05-27
Accepted
2022-05-27 16:10:08
Documents
9
Period of Report
2022-05-27

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea160740-6k_scisparcltd.htm 6-K 17932
2 PRESS RELEASE ISSUED BY SCISPARC LTD. ON MAY 27, 2022 TITLED "SCISPARC ANNOUNCES ea160740ex99-1_scisparcltd.htm EX-99.1 7960
3 SECURITIES PURCHASE AGREEMENT BETWEEN SCISPARC LTD. AND THE INVESTOR NAMED THERE ea160740ex99-2_scisparcltd.htm EX-99.2 213014
4 REGISTRATION RIGHTS AGREEMENT BETWEEN SCISPARC LTD. AND THE INVESTOR NAMED THERE ea160740ex99-3_scisparcltd.htm EX-99.3 187813
5 LETTER AGREEMENT WITH AEGIS CAPITAL CORP DATED MAY 27, 2022 ea160740ex99-4_scisparcltd.htm EX-99.4 50696
6 FORM OF ORDINARY SHARE PURCHASE WARRANT ea160740ex99-5_scisparcltd.htm EX-99.5 101892
7 FORM OF PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT ea160740ex99-6_scisparcltd.htm EX-99.6 88148
8 GRAPHIC ex99-1_001.jpg GRAPHIC 7418
9 GRAPHIC ex99-4_001.jpg GRAPHIC 1779
  Complete submission text file 0001213900-22-030109.txt   681591
Mailing Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916
Business Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916 972-3-6103100
SciSparc Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 22977497
SIC: 2834 Pharmaceutical Preparations